Daniel Miller, MD
Ophthalmology · Cincinnati, OHNPI 1487681987
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $51,670 of the $75,356 with a category attached, or 68.6%. 19 manufacturers reported payments, led by Genentech USA, Inc. at 36.9% of the total. Reporting peaked in 2022 at $22,345 and has fallen 97.2% since, to $628 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $465.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$28K
- Regeneron Healthcare Solutions, Inc.$15K
- Novartis$15K
- Genentech, Inc.$8K
- F. Hoffmann-la Roche AG$4K
- Alcon Research LLC$4K
- plus $2K from 13 others
Across 122 payments — averaging $18,536 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$2.2M
- F. Hoffmann-la Roche AG$12K
- AbbVie$10K
What the payments were for
- Consulting fees$51,67069%
- Speaking & faculty fees$17,22923%
- Travel & lodging$1,5752%
- Food & beverage$4,7826%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 38 | $27,805 |
| Regeneron Healthcare Solutions, Inc. | 32 | $15,102 |
| Novartis | 10 | $14,508 |
| Genentech, Inc. | 7 | $7,863 |
| F. Hoffmann-la Roche AG | 1 | $4,139 |
| Alcon Research LLC | 1 | $3,850 |
| Otsuka America Pharmaceutical, Inc. | 23 | $455 |
| Apellis Pharmaceuticals, Inc. | 9 | $402 |
| AbbVie(2 entities) | 11 | $285 |
| Alimera Sciences, Inc. | 11 | $217 |
| Carl Zeiss Meditec USA, Inc. | 1 | $153 |
| Astellas Pharma US Inc | 5 | $150 |
| Alcon | 4 | $121 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Eyepoint US, Inc. | 2 | $72 |
| Johnson & Johnson | 3 | $49 |
| Glaukos Corporation | 1 | $35 |
| Lombart Brothers, Inc. | 1 | $30 |
| Kala Pharmaceuticals, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$75,356 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 54 | $2,684 |
| Divalproex Sodium | 13 | $521 |
| Brimonidine Tartrate | 11 | $427 |
| Benztropine Mesylate | 16 | $307 |
| Omeprazole | 19 | $234 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 31 | $181 |
| Latanoprost | 16 | $51 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Cincinnati
- Robert OsherCincinnati$720K
- Christopher RiemannCincinnati$463K
- Anup KhatanaCincinnati$347K
- Michael SnyderCincinnati$216K
- Robert SiskCincinnati$46K
- Michael NordlundCincinnati$40K
- Adam KaufmanCincinnati$19K
- Haroon ChaudhryCincinnati$18K
- Karen KlugoCincinnati$17K
- Clara ChanCincinnati$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.